| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.083 | 0.06 |